| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigation |
1 Department of Nuclear Medicine, IBFM-CNR, Scientific Institute H San Raffaele, Milan, Italy; 2 Department of Urology, Technische Universität München, München, Germany; 3 Department of Radiology, Technische Universität München, München, Germany; 4 Institute of Pathology, Technische Universität München, München, Germany; and 5 Nuclear Medicine Department, Technische Universität München, München, Germany
Correspondence: For correspondence or reprints contact: Maria Picchio, MD, Department of Nuclear Medicine, Scientific Institute H San Raffaele, Via Olgettina 60, 20132 Milan, Italy. E-mail: maria.picchio{at}hsr.it
Lymph node involvement is a major prognostic factor in bladder cancer, but the accuracy of conventional imaging modalities for the prediction of regional and distant metastatic diseases is limited. This study was performed to compare the diagnostic accuracies of contrast-enhanced CT and PET with 11C-choline for the staging of urothelial bladder cancer. Methods: Twenty-seven patients (median age, 69.1 y) who had urothelial bladder cancer and who were referred for radical cystectomy and pelvic lymph node dissection (PLND) on the basis of a histologic evaluation after transurethral resection of bladder cancer (TURB) were studied. PET scanning, using 2 multiring whole-body tomographs, was performed 5 min after intravenous injection of approximately 370–500 MBq of 11C-choline. In addition, conventional bone scintigraphy and contrast-enhanced CT were performed. After imaging, cystectomy and PLND were performed in all patients. Pathologic 11C-choline uptake that could not be explained by intestinal activity was noted as a positive result. Node positivity was determined by size on CT: nodes measuring more than 1 cm in the long axis were described as being positive for tumor. Histopathologic findings were used as a reference. Results: The presence of residual bladder cancer (pTa–pT4) was correctly detected in 21 of 25 histologically tumor-positive patients (84%) by CT and in 24 of 25 patients (96%) by 11C-choline PET. Lymph node involvement was correctly detected in 4 of 8 patients (50%) by CT and in 5 of 8 patients (62%) by 11C-choline PET. The median size of the 3 nodes with false-negative PET results was 9 mm (range, 6–21 mm), and the median size of the metastatic lesions within the lymph nodes was 3 mm (range, 1–15 mm). CT resulted in 6 (22%) false-positive lymph nodes, whereas none was demonstrated by 11C-choline PET; these data indicated a significantly higher accuracy of PET than of CT (P < 0.01). Both modalities missed a small peritoneal metastasis verified by histologic evaluation. No positive results were obtained from bone scintigraphy. Conclusion: These preliminary data suggest that 11C-choline PET is comparable to CT for detecting residual bladder cancer after TURB but appears to be superior to CT for the evaluation of potential additional lymph node metastases. 11C-choline PET should be further evaluated for staging in patients who have bladder cancer and who are scheduled for radical cystectomy.
Key Words: PET • 11C-choline • bladder cancer • CT • staging
This article has been cited by other articles:
|
|
 |
|
  H.-J. Wester Nuclear Imaging Probes: from Bench to Bedside Clin. Cancer Res., June 15, 2007; 13(12): 3470 - 3481. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
